0000921582-25-000067
SEC filingIMAX reported record H1 box office of $579.2M, driving 6% revenue growth and 18% gross margin expansion.
For the six months ended June 30, 2025, IMAX reported total revenue of $178.4 million, up 6% from $168.1 million in the prior-year period. Gross profit increased 18% to $106.8 million, driving gross margin expansion from 54% to 60%. Net income attributable to common shareholders rose to $13.6 million ($0.25 per diluted share) from $6.9 million ($0.13 per diluted share) in H1 2024. Adjusted net income per diluted share improved to $0.40 from $0.33.
The revenue growth was primarily driven by a record first-half box office of $579.2 million (including booking fees), a 24% increase over the prior year, fueled by the Chinese local language film Ne Zha 2 (which became the highest-grossing IMAX release ever in China at $166 million) and strong Hollywood titles such as Mission: Impossible - The Final Reckoning, Sinners, and F1 The Movie. The box office strength flowed through to higher rental revenues in the Technology Products and Services segment and higher content fees in Content Solutions.
Selling, general and administrative expenses were essentially flat at $68.8 million, reflecting workforce reductions and a $2.5 million Employee Retention Credit benefit, partially offset by higher incentive compensation. Research and development expenses declined 32% to $2.9 million due to capitalization of film camera costs. The company recorded a credit loss reversal of $0.3 million versus an expense of $0.2 million in the prior year, reflecting improved collections.
Content Solutions revenue decreased 1% to $68.2 million, as the prior year benefited from the sale of worldwide rights to The Blue Angels documentary. Excluding that item, revenue grew on higher box office. Gross margin surged to 67% from 55%, driven by a higher mix of lower-cost remastering revenue versus self-produced content. The segment released 54 new films and other content in H1 2025, including 30 local language titles that generated over $222 million in box office (38% of global box office).
Technology Products and Services revenue increased 13% to $106.2 million, with gross margin expanding to 56% from 52%. The growth was led by a $5.2 million increase in JRSA rental revenues (box office-driven) and higher system installations (26 systems recognized under sales/sales-type leases vs. 16 in H1 2024). The company installed 57 total systems in H1 2025 (including 31 under JRSAs), up from 39 in the prior year. Backlog stood at 501 systems as of June 30, 2025, with 74% in international markets.
All Other (primarily Streaming and Consumer Technology) revenue declined 21% to $3.9 million, with gross margin falling to 39% from 65%, reflecting lower activity in this emerging segment.
Management highlighted a record number of over 14 Filmed for IMAX titles expected in 2025, with 30 additional films announced for the remainder of the year, including major releases like Jurassic World: Rebirth, Superman, Avatar: Fire and Ash, and Wicked: For Good. The company also announced a multi-year Hollywood slate beyond 2025 including The Odyssey, Avengers: Doomsday, and Narnia (exclusive two-week IMAX run in 2026).
International expansion remains a key priority, with 76% of the commercial multiplex network now outside the U.S. and Canada. The company estimates a worldwide commercial multiplex addressable market of 3,619 locations, with only 48% penetration. Management expects to fund operations through cash flows from operations and available credit facilities (increased to $375 million under a new credit agreement signed July 14, 2025). The company continues to invest in JRSA installations (336 systems in backlog) and laser upgrades (145 in backlog) to drive recurring revenue growth.
Operating cash flow of $30.2M exceeded net income of $20.4M, indicating solid cash conversion. The main drivers were depreciation & amortization ($30.8M) and share-based compensation ($12.8M), partly offset by a significant increase in accounts receivable ($18.7M) and film assets ($11.3M). Capex intensity rose to $18.7M (62% of operating cash flow), up from $12.4M (51%) in H1 2024, reflecting higher investment in joint revenue sharing equipment. Free cash flow (not explicitly stated) would be about $11.5M after capex, though working capital swings reduced it. Share repurchases fell sharply to $1.5M vs $18.1M, while no dividends were paid. Overall, cash generation remains strong but capital expenditures and working capital outflows consumed a larger portion of operating cash flow compared to prior year.